Harborview Rehabilitation And Care Center At Lansd | |
25 West Fifth Street, Lansdale, Pennsylvania 19446 | |
(215) 855-9765 | |
Name | Harborview Rehabilitation And Care Center At Lansd |
---|---|
Location | 25 West Fifth Street, Lansdale, Pennsylvania |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 126 |
Occupancy Rate | 71.03% |
Medicare ID (CCN) | 395256 |
Legal Business Name | Harborview Rehabilitation And Care Center At Lansdale Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1295278927 |
Organization Name | LANSDALE CARE AND REHABILITATION CENTER LLC |
Doing Business As | LANSDALE CARE AND REHABILITATION CENTER |
Address | 25 W 5th St, Lansdale, PA 19446 |
Phone Number | 215-855-9765 |
News Archive
The U.S. Embassy in Uganda announced a grant of $246 million in new aid for improving the Uganda's agricultural and health systems, Reuters reports. "More than $170 million will be spent on health and education to combat the HIV/AIDS pandemic, fight tuberculosis, eradicate malaria, improve maternal and child health and increase access to family planning and reproductive health services," the news service writes (Biryabarema, 10/27).
A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes - all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the secured debt held by Platinum-Montaur Life Sciences, LLC has been converted into a newly created Series C Preferred Stock of the Company. As a result of the conversion, the lien on the Company's assets, including its intellectual property will be extinguished.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
› Verified 1 days ago
NPI Number | 1558312959 |
Organization Name | GGNSC LANSDALE LP |
Doing Business As | GOLDEN LIVINGCENTER - LANSDALE |
Address | 25 W 5th St, Lansdale, PA 19446 |
Phone Number | 215-855-9765 |
News Archive
The U.S. Embassy in Uganda announced a grant of $246 million in new aid for improving the Uganda's agricultural and health systems, Reuters reports. "More than $170 million will be spent on health and education to combat the HIV/AIDS pandemic, fight tuberculosis, eradicate malaria, improve maternal and child health and increase access to family planning and reproductive health services," the news service writes (Biryabarema, 10/27).
A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes - all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the secured debt held by Platinum-Montaur Life Sciences, LLC has been converted into a newly created Series C Preferred Stock of the Company. As a result of the conversion, the lien on the Company's assets, including its intellectual property will be extinguished.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
› Verified 1 days ago
NPI Number | 1942790332 |
Organization Name | HARBORVIEW REHABILITATION AND CARE CENTER AT LANSDALE LLC |
Doing Business As | HARBORVIEW REHABILITATION AND CARE CENTER AT LANSDALE |
Address | 25 W 5th St, Lansdale, PA 19446 |
Phone Number | 215-855-9765 |
News Archive
The U.S. Embassy in Uganda announced a grant of $246 million in new aid for improving the Uganda's agricultural and health systems, Reuters reports. "More than $170 million will be spent on health and education to combat the HIV/AIDS pandemic, fight tuberculosis, eradicate malaria, improve maternal and child health and increase access to family planning and reproductive health services," the news service writes (Biryabarema, 10/27).
A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes - all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the secured debt held by Platinum-Montaur Life Sciences, LLC has been converted into a newly created Series C Preferred Stock of the Company. As a result of the conversion, the lien on the Company's assets, including its intellectual property will be extinguished.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
› Verified 1 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The U.S. Embassy in Uganda announced a grant of $246 million in new aid for improving the Uganda's agricultural and health systems, Reuters reports. "More than $170 million will be spent on health and education to combat the HIV/AIDS pandemic, fight tuberculosis, eradicate malaria, improve maternal and child health and increase access to family planning and reproductive health services," the news service writes (Biryabarema, 10/27).
A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes - all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the secured debt held by Platinum-Montaur Life Sciences, LLC has been converted into a newly created Series C Preferred Stock of the Company. As a result of the conversion, the lien on the Company's assets, including its intellectual property will be extinguished.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
› Verified 1 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 31.72 | 14.46 |
Percentage of long-stay residents who lose too much weight | 12.79 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 21.05 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 0.87 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0.27 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.07 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.4 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 22.26 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.33 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.4 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 51.48 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.39 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 3.47 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 66.36 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 59.05 | 82.93 |
News Archive
The U.S. Embassy in Uganda announced a grant of $246 million in new aid for improving the Uganda's agricultural and health systems, Reuters reports. "More than $170 million will be spent on health and education to combat the HIV/AIDS pandemic, fight tuberculosis, eradicate malaria, improve maternal and child health and increase access to family planning and reproductive health services," the news service writes (Biryabarema, 10/27).
A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes - all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.
Urigen Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that the secured debt held by Platinum-Montaur Life Sciences, LLC has been converted into a newly created Series C Preferred Stock of the Company. As a result of the conversion, the lien on the Company's assets, including its intellectual property will be extinguished.
St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.
› Verified 1 days ago
Harborview Rehabilitation And Care Center At Lansd Location: 25 West Fifth Street, Lansdale, Pennsylvania 19446 Phone: (215) 855-9765 | |
Gwynedd Healthcare And Rehabilitation Center Location: 773 Sumneytown Pike, Lansdale, Pennsylvania 19446 Phone: (215) 699-5000 | |
Elm Terrace Gardens Location: 660 North Broad Street, Lansdale, Pennsylvania 19446 Phone: (215) 361-5600 | |
St Mary Center For Rehabilitation & Healthcare Location: 701 Lansdale Avenue, Lansdale, Pennsylvania 19446 Phone: (215) 368-0900 | |
Willowbrooke Court Skilled Care Center At Brittany Location: 1001 Valley Forge Road, Lansdale, Pennsylvania 19446 Phone: (215) 855-9700 |